ID   PUR9_HUMAN              Reviewed;         592 AA.
AC   P31939; A8K202; E9PBU3; Q13856; Q53S28;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2002, sequence version 3.
DT   12-APR-2017, entry version 179.
DE   RecName: Full=Bifunctional purine biosynthesis protein PURH;
DE   Includes:
DE     RecName: Full=Phosphoribosylaminoimidazolecarboxamide formyltransferase;
DE              EC=2.1.2.3;
DE     AltName: Full=5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase;
DE     AltName: Full=AICAR transformylase;
DE   Includes:
DE     RecName: Full=IMP cyclohydrolase;
DE              EC=3.5.4.10;
DE     AltName: Full=ATIC;
DE     AltName: Full=IMP synthase;
DE     AltName: Full=Inosinicase;
DE   Contains:
DE     RecName: Full=Bifunctional purine biosynthesis protein PURH, N-terminally processed;
GN   Name=ATIC; Synonyms=PURH; ORFNames=OK/SW-cl.86;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Hepatoma;
RX   PubMed=8567683; DOI=10.1074/jbc.271.4.2225;
RA   Rayl E.A., Moroson B.A., Beardsley G.P.;
RT   "The human purH gene product, 5-aminoimidazole-4-carboxamide
RT   ribonucleotide formyltransferase/IMP cyclohydrolase. Cloning,
RT   sequencing, expression, purification, kinetic analysis, and domain
RT   mapping.";
RL   J. Biol. Chem. 271:2225-2233(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=8867801; DOI=10.1093/dnares/2.6.269;
RA   Yamauchi M., Seki N., Mita K., Saito T., Tsuji S., Hongo E.,
RA   Morimyo M., Shiomi T., Koyama H.;
RT   "Isolation of human purH gene expressed in the rodent transformant
RT   cells by subtractive enrichment of 3'-untranslated region of human
RT   transcript.";
RL   DNA Res. 2:269-275(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=9378707; DOI=10.1093/oxfordjournals.jbchem.a021754;
RA   Sugita T., Aya H., Ueno M., Ishizuka T., Kawashima K.;
RT   "Characterization of molecularly cloned human 5-aminoimidazole-4-
RT   carboxamide ribonucleotide transformylase.";
RL   J. Biochem. 122:309-313(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-
RT   reactive CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   SER-116.
RC   TISSUE=Substantia nigra;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-116.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 15-39; 91-97; 178-194; 208-225; 267-285 AND
RP   417-426, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 178-189 AND 267-281.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=25687571; DOI=10.1074/mcp.M114.047159;
RA   Boutchueng-Djidjou M., Collard-Simard G., Fortier S., Hebert S.S.,
RA   Kelly I., Landry C.R., Faure R.L.;
RT   "The last enzyme of the de novo purine synthesis pathway 5-
RT   aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP
RT   cyclohydrolase (ATIC) plays a central role in insulin signaling and
RT   the Golgi/endosomes protein network.";
RL   Mol. Cell. Proteomics 14:1079-1092(2015).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH XMP, AND
RP   SUBUNIT.
RX   PubMed=14756553; DOI=10.1021/bi030162i;
RA   Wolan D.W., Cheong C.-G., Greasley S.E., Wilson I.A.;
RT   "Structural insights into the human and avian IMP cyclohydrolase
RT   mechanism via crystal structures with the bound XMP inhibitor.";
RL   Biochemistry 43:1171-1183(2004).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) IN COMPLEX WITH AICAR; XMP AND
RP   THE INHIBITORS BW1540 AND BW2315, FUNCTION, AND SUBUNIT.
RX   PubMed=14966129; DOI=10.1074/jbc.M313691200;
RA   Cheong C.-G., Wolan D.W., Greasley S.E., Horton P.A., Beardsley G.P.,
RA   Wilson I.A.;
RT   "Crystal structures of human bifunctional enzyme aminoimidazole-4-
RT   carboxamide ribonucleotide transformylase/IMP cyclohydrolase in
RT   complex with potent sulfonyl-containing antifolates.";
RL   J. Biol. Chem. 279:18034-18045(2004).
RN   [20]
RP   VARIANT AICAR ARG-426, AND CHARACTERIZATION OF VARIANT AICAR ARG-426.
RX   PubMed=15114530; DOI=10.1086/421475;
RA   Marie S., Heron B., Bitoun P., Timmerman T., Van Den Berghe G.,
RA   Vincent M.-F.;
RT   "AICA-ribosiduria: a novel, neurologically devastating inborn error of
RT   purine biosynthesis caused by mutation of ATIC.";
RL   Am. J. Hum. Genet. 74:1276-1281(2004).
CC   -!- FUNCTION: Bifunctional enzyme that catalyzes 2 steps in purine
CC       biosynthesis. {ECO:0000269|PubMed:14966129}.
CC   -!- FUNCTION: Promotes insulin receptor/INSR autophosphorylation and
CC       is involved in INSR internalization (PubMed:25687571).
CC       {ECO:0000269|PubMed:25687571}.
CC   -!- CATALYTIC ACTIVITY: 10-formyltetrahydrofolate + 5-amino-1-(5-
CC       phospho-D-ribosyl)imidazole-4-carboxamide = tetrahydrofolate + 5-
CC       formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide.
CC   -!- CATALYTIC ACTIVITY: IMP + H(2)O = 5-formamido-1-(5-phospho-D-
CC       ribosyl)imidazole-4-carboxamide.
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway;
CC       5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-
CC       amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl
CC       THF route): step 1/1.
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway;
CC       IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-
CC       carboxamide: step 1/1.
CC   -!- SUBUNIT: Homodimer (PubMed:14756553, PubMed:14966129). Associates
CC       with internalized INSR complexes on Golgi/endosomal membranes.
CC       Interacts with INSR; ATIC together with PRKAA2/AMPK2 and
CC       HACD3/PTPLAD1 is proposed to be part of a signaling network
CC       regulating INSR autophosphorylation and endocytosis
CC       (PubMed:25687571). {ECO:0000269|PubMed:14756553,
CC       ECO:0000269|PubMed:14966129, ECO:0000269|PubMed:25687571}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P31939-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P31939-2; Sequence=VSP_053495;
CC   -!- DOMAIN: The IMP cyclohydrolase activity resides in the N-terminal
CC       region.
CC   -!- DISEASE: AICAR transformylase/IMP cyclohydrolase deficiency
CC       (AICAR) [MIM:608688]: A neurologically devastating inborn error of
CC       purine biosynthesis. Patients excrete massive amounts of AICA-
CC       riboside in the urine and accumulate AICA-ribotide and its
CC       derivatives in erythrocytes and fibroblasts. AICAR causes profound
CC       mental retardation, epilepsy, dysmorphic features and congenital
CC       blindness. {ECO:0000269|PubMed:15114530}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PurH family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ATICID227.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U37436; AAA97405.1; -; mRNA.
DR   EMBL; D82348; BAA11559.1; -; mRNA.
DR   EMBL; D89976; BAA21762.1; -; mRNA.
DR   EMBL; AB062403; BAB93490.1; -; mRNA.
DR   EMBL; AK290067; BAF82756.1; -; mRNA.
DR   EMBL; AC073284; AAY24062.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70529.1; -; Genomic_DNA.
DR   EMBL; BC008879; AAH08879.1; -; mRNA.
DR   CCDS; CCDS2398.1; -. [P31939-1]
DR   PIR; JC4642; JC4642.
DR   RefSeq; NP_004035.2; NM_004044.6. [P31939-1]
DR   UniGene; Hs.90280; -.
DR   PDB; 1P4R; X-ray; 2.55 A; A/B=1-592.
DR   PDB; 1PKX; X-ray; 1.90 A; A/B/C/D=1-592.
DR   PDB; 1PL0; X-ray; 2.60 A; A/B/C/D=1-592.
DR   PDBsum; 1P4R; -.
DR   PDBsum; 1PKX; -.
DR   PDBsum; 1PL0; -.
DR   ProteinModelPortal; P31939; -.
DR   SMR; P31939; -.
DR   BioGrid; 106961; 70.
DR   IntAct; P31939; 9.
DR   MINT; MINT-4999053; -.
DR   STRING; 9606.ENSP00000236959; -.
DR   BindingDB; P31939; -.
DR   ChEMBL; CHEMBL2518; -.
DR   DrugBank; DB03442; 2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid.
DR   DrugBank; DB02309; 5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine.
DR   DrugBank; DB01700; Aicar.
DR   DrugBank; DB01972; Guanosine-5'-Monophosphate.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB00642; Pemetrexed.
DR   DrugBank; DB00116; Tetrahydrofolic acid.
DR   iPTMnet; P31939; -.
DR   PhosphoSitePlus; P31939; -.
DR   SwissPalm; P31939; -.
DR   BioMuta; ATIC; -.
DR   DMDM; 23831360; -.
DR   REPRODUCTION-2DPAGE; IPI00289499; -.
DR   UCD-2DPAGE; P31939; -.
DR   EPD; P31939; -.
DR   PaxDb; P31939; -.
DR   PeptideAtlas; P31939; -.
DR   PRIDE; P31939; -.
DR   DNASU; 471; -.
DR   Ensembl; ENST00000236959; ENSP00000236959; ENSG00000138363. [P31939-1]
DR   Ensembl; ENST00000435675; ENSP00000415935; ENSG00000138363. [P31939-2]
DR   GeneID; 471; -.
DR   KEGG; hsa:471; -.
DR   UCSC; uc002vey.5; human. [P31939-1]
DR   CTD; 471; -.
DR   DisGeNET; 471; -.
DR   GeneCards; ATIC; -.
DR   HGNC; HGNC:794; ATIC.
DR   HPA; CAB013462; -.
DR   HPA; HPA021012; -.
DR   MalaCards; ATIC; -.
DR   MIM; 601731; gene.
DR   MIM; 608688; phenotype.
DR   neXtProt; NX_P31939; -.
DR   OpenTargets; ENSG00000138363; -.
DR   Orphanet; 250977; AICA-ribosiduria.
DR   PharmGKB; PA25094; -.
DR   eggNOG; KOG2555; Eukaryota.
DR   eggNOG; COG0138; LUCA.
DR   GeneTree; ENSGT00390000004553; -.
DR   HOGENOM; HOG000230372; -.
DR   HOVERGEN; HBG006912; -.
DR   InParanoid; P31939; -.
DR   KO; K00602; -.
DR   OMA; PCGVAEG; -.
DR   OrthoDB; EOG091G03H4; -.
DR   PhylomeDB; P31939; -.
DR   TreeFam; TF105642; -.
DR   BioCyc; MetaCyc:HS06490-MONOMER; -.
DR   BRENDA; 2.1.2.3; 2681.
DR   BRENDA; 3.5.4.10; 2681.
DR   Reactome; R-HSA-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   SABIO-RK; P31939; -.
DR   UniPathway; UPA00074; UER00133.
DR   UniPathway; UPA00074; UER00135.
DR   ChiTaRS; ATIC; human.
DR   EvolutionaryTrace; P31939; -.
DR   GeneWiki; Inosine_monophosphate_synthase; -.
DR   GenomeRNAi; 471; -.
DR   PRO; PR:P31939; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000138363; -.
DR   CleanEx; HS_ATIC; -.
DR   ExpressionAtlas; P31939; baseline and differential.
DR   Genevisible; P31939; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0003937; F:IMP cyclohydrolase activity; TAS:Reactome.
DR   GO; GO:0004643; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity; TAS:Reactome.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0003360; P:brainstem development; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0046452; P:dihydrofolate metabolic process; IEA:Ensembl.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0009116; P:nucleoside metabolic process; IEA:Ensembl.
DR   GO; GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome.
DR   GO; GO:0010035; P:response to inorganic substance; IEA:Ensembl.
DR   GO; GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:Ensembl.
DR   Gene3D; 3.40.140.20; -; 2.
DR   Gene3D; 3.40.50.1380; -; 1.
DR   HAMAP; MF_00139; PurH; 1.
DR   InterPro; IPR024051; AICAR_Tfase_dom.
DR   InterPro; IPR002695; AICARFT_IMPCHas.
DR   InterPro; IPR016193; Cytidine_deaminase-like.
DR   InterPro; IPR011607; MGS-like_dom.
DR   PANTHER; PTHR11692; PTHR11692; 1.
DR   Pfam; PF01808; AICARFT_IMPCHas; 1.
DR   Pfam; PF02142; MGS; 1.
DR   PIRSF; PIRSF000414; AICARFT_IMPCHas; 1.
DR   SMART; SM00798; AICARFT_IMPCHas; 1.
DR   SMART; SM00851; MGS; 1.
DR   SUPFAM; SSF52335; SSF52335; 1.
DR   SUPFAM; SSF53927; SSF53927; 1.
DR   TIGRFAMs; TIGR00355; purH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Epilepsy; Hydrolase;
KW   Multifunctional enzyme; Polymorphism; Purine biosynthesis;
KW   Reference proteome; Transferase.
FT   CHAIN         1    592       Bifunctional purine biosynthesis protein
FT                                PURH.
FT                                /FTId=PRO_0000192156.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    592       Bifunctional purine biosynthesis protein
FT                                PURH, N-terminally processed.
FT                                /FTId=PRO_0000434376.
FT   NP_BIND      12     14       IMP.
FT   NP_BIND      34     37       IMP.
FT   NP_BIND      64     67       IMP.
FT   NP_BIND     101    104       IMP.
FT   NP_BIND     125    127       IMP.
FT   REGION      207    208       AICAR binding.
FT   ACT_SITE    137    137       Proton acceptor. {ECO:0000255}.
FT   ACT_SITE    267    267       Proton acceptor. {ECO:0000305}.
FT   BINDING     316    316       AICAR; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:14966129}.
FT   BINDING     339    339       AICAR. {ECO:0000269|PubMed:14966129}.
FT   BINDING     431    431       AICAR; shared with dimeric partner.
FT                                {ECO:0000269|PubMed:14966129}.
FT   BINDING     451    451       AICAR; shared with dimeric partner.
FT                                {ECO:0000269|PubMed:14966129}.
FT   BINDING     541    541       AICAR; via carbonyl oxygen; shared with
FT                                dimeric partner.
FT                                {ECO:0000269|PubMed:14966129}.
FT   BINDING     588    588       AICAR; shared with dimeric partner.
FT                                {ECO:0000269|PubMed:14966129}.
FT   SITE        266    266       Transition state stabilizer.
FT                                {ECO:0000255}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     199    199       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1      6       MAPGQL -> MSSLS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:8567683}.
FT                                /FTId=VSP_053495.
FT   VARIANT     116    116       T -> S (in dbSNP:rs2372536).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_019306.
FT   VARIANT     426    426       K -> R (in AICAR; loss of transformylase
FT                                activity; dbSNP:rs121434478).
FT                                {ECO:0000269|PubMed:15114530}.
FT                                /FTId=VAR_019307.
FT   CONFLICT    165    165       D -> G (in Ref. 1; AAA97405).
FT                                {ECO:0000305}.
FT   STRAND        6     10       {ECO:0000244|PDB:1PKX}.
FT   HELIX        17     25       {ECO:0000244|PDB:1PKX}.
FT   TURN         26     28       {ECO:0000244|PDB:1PKX}.
FT   STRAND       30     33       {ECO:0000244|PDB:1PKX}.
FT   HELIX        35     42       {ECO:0000244|PDB:1PKX}.
FT   TURN         43     45       {ECO:0000244|PDB:1PKX}.
FT   HELIX        51     55       {ECO:0000244|PDB:1PKX}.
FT   TURN         61     64       {ECO:0000244|PDB:1PKX}.
FT   STRAND       65     67       {ECO:0000244|PDB:1PKX}.
FT   HELIX        70     77       {ECO:0000244|PDB:1PKX}.
FT   HELIX        82     91       {ECO:0000244|PDB:1PKX}.
FT   STRAND       96    101       {ECO:0000244|PDB:1PKX}.
FT   HELIX       106    111       {ECO:0000244|PDB:1PKX}.
FT   HELIX       117    122       {ECO:0000244|PDB:1PKX}.
FT   HELIX       127    137       {ECO:0000244|PDB:1PKX}.
FT   TURN        138    141       {ECO:0000244|PDB:1PKX}.
FT   STRAND      143    145       {ECO:0000244|PDB:1PKX}.
FT   HELIX       148    150       {ECO:0000244|PDB:1PKX}.
FT   HELIX       151    160       {ECO:0000244|PDB:1PKX}.
FT   STRAND      161    165       {ECO:0000244|PDB:1P4R}.
FT   HELIX       168    197       {ECO:0000244|PDB:1PKX}.
FT   TURN        200    202       {ECO:0000244|PDB:1PKX}.
FT   STRAND      203    207       {ECO:0000244|PDB:1PKX}.
FT   STRAND      209    211       {ECO:0000244|PDB:1PKX}.
FT   STRAND      217    220       {ECO:0000244|PDB:1PKX}.
FT   STRAND      222    225       {ECO:0000244|PDB:1PKX}.
FT   STRAND      227    233       {ECO:0000244|PDB:1PKX}.
FT   HELIX       237    257       {ECO:0000244|PDB:1PKX}.
FT   STRAND      261    266       {ECO:0000244|PDB:1PKX}.
FT   STRAND      269    275       {ECO:0000244|PDB:1PKX}.
FT   HELIX       281    286       {ECO:0000244|PDB:1PKX}.
FT   HELIX       290    295       {ECO:0000244|PDB:1PKX}.
FT   HELIX       298    308       {ECO:0000244|PDB:1PKX}.
FT   TURN        311    316       {ECO:0000244|PDB:1PKX}.
FT   STRAND      317    323       {ECO:0000244|PDB:1PKX}.
FT   HELIX       327    334       {ECO:0000244|PDB:1PKX}.
FT   STRAND      338    344       {ECO:0000244|PDB:1PKX}.
FT   HELIX       348    360       {ECO:0000244|PDB:1PKX}.
FT   STRAND      363    367       {ECO:0000244|PDB:1PKX}.
FT   STRAND      375    381       {ECO:0000244|PDB:1PKX}.
FT   STRAND      384    389       {ECO:0000244|PDB:1PKX}.
FT   HELIX       397    400       {ECO:0000244|PDB:1PKX}.
FT   HELIX       412    426       {ECO:0000244|PDB:1PKX}.
FT   STRAND      433    437       {ECO:0000244|PDB:1PKX}.
FT   STRAND      440    445       {ECO:0000244|PDB:1PKX}.
FT   HELIX       451    467       {ECO:0000244|PDB:1PKX}.
FT   HELIX       471    474       {ECO:0000244|PDB:1PKX}.
FT   HELIX       486    496       {ECO:0000244|PDB:1PKX}.
FT   HELIX       503    509       {ECO:0000244|PDB:1PKX}.
FT   STRAND      512    514       {ECO:0000244|PDB:1PKX}.
FT   HELIX       521    528       {ECO:0000244|PDB:1PKX}.
FT   STRAND      534    540       {ECO:0000244|PDB:1PKX}.
FT   STRAND      543    545       {ECO:0000244|PDB:1PL0}.
FT   HELIX       546    552       {ECO:0000244|PDB:1PKX}.
FT   TURN        553    555       {ECO:0000244|PDB:1PKX}.
FT   STRAND      556    562       {ECO:0000244|PDB:1PKX}.
FT   HELIX       568    578       {ECO:0000244|PDB:1PKX}.
FT   STRAND      581    586       {ECO:0000244|PDB:1PKX}.
SQ   SEQUENCE   592 AA;  64616 MW;  AD778892021F0888 CRC64;
     MAPGQLALFS VSDKTGLVEF ARNLTALGLN LVASGGTAKA LRDAGLAVRD VSELTGFPEM
     LGGRVKTLHP AVHAGILARN IPEDNADMAR LDFNLIRVVA CNLYPFVKTV ASPGVTVEEA
     VEQIDIGGVT LLRAAAKNHA RVTVVCEPED YVVVSTEMQS SESKDTSLET RRQLALKAFT
     HTAQYDEAIS DYFRKQYSKG VSQMPLRYGM NPHQTPAQLY TLQPKLPITV LNGAPGFINL
     CDALNAWQLV KELKEALGIP AAASFKHVSP AGAAVGIPLS EDEAKVCMVY DLYKTLTPIS
     AAYARARGAD RMSSFGDFVA LSDVCDVPTA KIISREVSDG IIAPGYEEEA LTILSKKKNG
     NYCVLQMDQS YKPDENEVRT LFGLHLSQKR NNGVVDKSLF SNVVTKNKDL PESALRDLIV
     ATIAVKYTQS NSVCYAKNGQ VIGIGAGQQS RIHCTRLAGD KANYWWLRHH PQVLSMKFKT
     GVKRAEISNA IDQYVTGTIG EDEDLIKWKA LFEEVPELLT EAEKKEWVEK LTEVSISSDA
     FFPFRDNVDR AKRSGVAYIA APSGSAADKV VIEACDELGI ILAHTNLRLF HH
//
